2023 Volume 66 Issue 1 Pages 9-17
The purpose of this study was to demonstrate the effect of constructing and implementing the "Aichi Model for Medical Collaboration" via HbA1c measurement at pharmacies on prevention, early detection, and early treatment of diabetes mellitus. A specimen measurement room was set up at a pharmacy, and the applicants who wished to undergo sampling under the guidance of the pharmacist self-punctured themselves and measured their blood HbA1c. Based on the rules for setting up the "Aichi Model for Medical Collaboration", pharmacists informed the examinees of the measurement results and recommended they undergo medical examinations at medical institutions when appropriate. The results showed that 498 subjects (average age 47.2 years old) had an average HbA1c of 5.5 %. Among the 92 people (18.6 %) with an HbA1c of ≥6.0 %, 72 (14.5 %) consulted a medical institution. Of the 37 cases that were able to be followed up, 16 consulted a medical institution and started treatment, and the average HbA1c before consultation was 7.0 %, but the confirmed HbA1c significantly improved to 6.5 %. The implementation of the "Aichi Model for Medical Cooperation" by measuring samples at a local pharmacy may lead to the early detection and early treatment of diabetes. We would like to study the cost-effectiveness of this model in the future.
